ACST

Acasti Pharma, Inc.

2.75 USD
-0.50 (-15.38%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Acasti Pharma, Inc. stock is down -1.43% since 30 days ago. The next earnings date is Jun 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 11 June’s closed higher than May.

About Acasti Pharma, Inc.

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia.